• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • US
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Products
    • US Products By Brand
    • Patient Assistance
    • Product Portfolio
    • Our Process
    • Therapeutic Areas
    • Product Related Issues
  • About Us
    • Novartis US at a Glance
    • Who We Are
    • Diversity & Inclusion
    • Our Leadership
    • Research
    • Contact Us
  • Corporate Responsibility
    • Novartis in Society US Reports
    • External Funding
    • Corporate Citizenship
    • Business Conduct
    • Corporate Integrity Agreement
    • Payments to HCPs & HCOs
    • Post-Marketing Commitments
    • Enhanced Verification Request
    • Beacon of Hope
  • News
    • News Archive
    • Statements
    • Stories
    • The STEP Program
    • US Media Contacts
    • Novartis US COVID-19 Initiatives
  • Careers
    • Careers Search
    • Working at Novartis
    • Career Paths
    • Career Programs
    • Employee Benefits
    • Awards & Recognition
    • NIBR Careers Frequently Asked Questions
Search

Discovery

  • All topics
  • Medicines
  • Discovery
  • Hope
  • Global Impact
  • Education & Awareness

Discovery

Subscribe
Scientists are working to develop drugs for individuals living with sickle cell disease

Shaping the future of sickle cell disease

Phil Gotwals and colleagues discuss advanced therapy platforms.

Sourcing innovation, strategically

Novartis scientist talks to woman on the street.

Word on the Street: What is cell and gene therapy?

Novartis United States

  • Our Products
  • About Us
  • News
  • Careers
  • Contact Us
  • Corporate Responsibility
  • Locations

Subscribe to Novartis

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Instagram
  • Novartis Site Directory
© 2022 Novartis Pharmaceuticals Corporation

This site is intended for US Residents Only

  • Terms of Use
  • Privacy Policy
  • About Cookies